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Two strains of simian immunodeficiency viruses (SIV) isolated from chimpanzees (SIVCPZ-GAB and SIVCPZ-GAB2) originating
from Gabon have previously been genetically characterized and shown to belong phylogenetically to the same lineage
as the human immunodeficiency virus type 1 (HIV-1). We describe the sequence analysis of a third HIV-1-related virus,
SIVCPZ-ANT , isolated from a wild captured chimpanzee originating from Zaire. This virus displayed the same genetic organiza-
tion as HIV-1 and was found to fall on the same lineage as HIV-1 and SIVCPZ-GAB . Protein sequence identity with SIVCPZ-GAB
ranged from 72% (Pol) to 48% (Env) for the structural proteins, while a particularly divergent Vpu was found (only 25%
identity to SIVCPZ-GAB). The V3 regions of the SIVCPZ isolates were exceptionally conserved in contrast to the high divergence
of V3 among HIV-1 isolates. However, SIVCPZ-ANT did not show a greater degree of sequence similarity with SIVCPZ-GAB than
with HIV-1 isolates and represents a quite divergent outgroup of the HIV-1 lineage. Our data suggest multiple introductions
of HIV-1 in the human population and shed new light on the origin of the HIV-1 pandemic. q 1996 Academic Press, Inc.
Lentiviruses have been isolated from a variety of pri- been suggested that most SIV (including viruses from
chimpanzees, African green monkeys, and sooty manga-mate species and constitute human immunodeficiency
virus types 1 and 2 (HIV-1 and HIV-2, which cause AIDS) beys) may have arisen through cross-species transmis-
sion from humans (10, 11). Phylogenetic analyses of re-and simian immunodeficiency viruses (SIV) isolated from
nonhuman primates. Phylogenetic analysis indicates that cently isolated HIV-1 variants reveal that there are two
major lineages, named groups M and O: the two Gabo-these viruses form five major lineages, with the two hu-
man viruses falling into different lineages (1, 2). HIV-2 is nese chimpanzee viruses cluster with group M (7) and
thus within the HIV-1 radiation. While this relationshipmost closely related to SIVSM , isolated from sooty manga-
beys, and various lines of evidence suggest that HIV-2 would indeed seem to be most simply explained by hu-
man-to-chimpanzee transmission, it has been pointedhas arisen through cross-species transmission of SIV
from sooty mangabeys in West Africa (3–5). out that cross-species transmission of primate lentivi-
ruses has been frequent enough to undermine the parsi-The origin of HIV-1 is less clear. Two closely related
SIVs, both derived from seropositive chimpanzees in Ga- mony argument used to make this inference (12). A third
hypothesis is that both humans and chimpanzees maybon, have been described. For SIVCPZ-GAB , a complete
sequence is available (6), but information on the second, have acquired lentiviruses from a third species; a number
of other African monkey species have been reported toSIVCPZ-GAB2 , is limited to 280 bp from the pol region (7).
Although both chimpanzee viruses fall on the same lin- be seropositive for lentiviruses (13), but these viruses
have yet to be characterized.eage as HIV-1 (6, 7), the epidemiological relationships
between the human and chimpanzee viruses—and thus We now report on the molecular cloning of a third
chimpanzee virus, SIVCPZ-ANT , which was previously iso-the origin of HIV-1—are uncertain. First, it is not known
whether chimpanzees are the natural reservoirs for HIV- lated from a wild captured HIV-seropositive chimpanzee
originating from Zaire. The complete SIVCPZ-ANT genome1 since only 3/94 animals tested are serologically SIV
positive (8). In contrast, 30–50% of adult sooty manga- was obtained by polymerase chain reaction (PCR) gener-
ating six overlapping genomic fragments. The SIVCPZ-ANTbeys in the wild are infected with SIV (9). Second, it has
genome has a genetic organization typical for members
of the HIV-1 family and encodes nine genes, including1 To whom correspondence and reprint requests should be ad-
dressed. Fax: /32-9-2410799. vpu which is unique to this lineage. This is consistent
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TABLE 1
Amino Acid Sequence Identity (%) between SIVCPZ-ANT , SIVCPZ-GAB , and Prototype HIV/SIV Isolatesa
SIVCPZ-ANT
compared
withb GAG POL VIF VPR VPU TAT ENV REV NEF
SIVCPZ-GAB 65 72 52 62 25 57 48 42 51
HIVMN (M) 59 71 54 61 17 61 47 37 47
HIVANT70 (O) 63 70 50 61 19 52 43 57 53
SIVAGM 52 60 26 — — 34 36 31 43
SIVSMM 51 58 32 46 — 39 37 17 41
SIVMND 51 58 27 48 — 42 31 20 31
SIVSYK 46 54 28 25 — 40 41 34 38
a Chromosomal DNA was prepared from human lymphocytes infected in vitro with the SIVCPZ-ANT virus isolate. Regions highly conserved between
HIV-1 and SIVCPZ-GAB were chosen to design oligonucleotides (and nested oligonucleotides) to prime the reactions. In later experiments, reactions
were primed using oligonucleotides derived from the SIVCPZ-ANT sequences themselves. In most cases, the following reaction conditions were used:
a 1-min denaturation step at 957C, a 2-min annealing step at 377C or 507C, and 1- to 2-min elongation step at 727C. For the majority of the regions,
a PCR consisting of 30 cycles was insufficient and a second PCR of 30 cycles was needed, using a nested primer pair. The resulting amplification
products were tested upon hybridization with HIV-1 probes under low stringency conditions as described (28). Sequence analysis was performed
on cloned PCR fragments using the dideoxy chain termination method (29), and the sequence has been deposited in the GenBank/EMBL database
(accession number U42720).
b Sequences were aligned using the program Palign (PCgene software package, structure-genetic matrix). The program parameters open gap
penalty and unit gap penalty were both set at five. For each alignment, the SIVCPZ-ANT protein sequence was compared individually to the corresponding
protein of the following strains: SIVCPZ-GAB , HIVMN (representative of group M within the HIV-1 lineage), HIVANT70 (representative of group O within
the HIV-1 lineage), SIVAGM (TYO) , SIVSMM (PBJ) , SIVMND (GB1) , and SIVSYK(KEN) .
with serological data which also indicate that this virus protein is remarkable for two reasons: first, compared to
SIVCPZ-GAB , four extra cysteine residues are present atbelongs to the HIV-1 family (14). Although we do not
know whether the sequence described here represents a positions 614, 623, 706, and 788 (Fig. 2A); second, only
four cysteine residues are found at equivalent positionsbiologically functional clone, virus can readily be isolated
from the infected animal (15). As within primate lentivi- when both SIV envelope proteins are aligned (residues
591, 597, 776, and 795). The only SIV subtype currentlyruses in general, the proteins encoded by gag and pol
are more conserved than the envelope or regulatory pro- known to contain a larger number of cysteine residues
in its transmembrane protein is SIVAGM , whereas in someteins (Table 1). From these protein sequence compari-
sons, SIVCPZ-ANT is clearly more similar to SIVCPZ-GAB and primary HIV-1 isolates extra cysteine residues have also
been observed (16). The structural implications resultingHIV-1 than to representatives of the other four major
lineages but, surprisingly, SIVCPZ-ANT does not seem to from these changes are presently unknown. The addi-
tional cysteine residues in SIVCPZ-ANT might have conse-be more similar to SIVCPZ-GAB than to HIV-1 isolates. We
therefore performed phylogenetic analyses to examine quences for folding, and thus for local epitope presenta-
tion of the protein, since they are likely to provide extrathe relationship of SIVCPZ-ANT to other primate lentiviruses.
SIVCPZ-ANT was found to fall on the same lineage as HIV- disulfide bridges (16, 17). In accordance with the high
sequence divergence found for these envelope proteins,1 and SIV CPZ-GAB , but as an outgroup (Fig. 1).
To better appreciate the degree of divergence of only limited cross-reactivity of HIV-1 antibody-positive
sera has been observed with the trans and outer mem-SIVCPZ-ANT (Table 1), we investigated the different coding
regions and, in particular, the alignments of the env and brane proteins of SIVCPZ-ANT and, typically, only 1–2% of
HIV-1 sera recognize these glycoproteins (14). While thevpu sequences. The complete envelope glycoprotein
was 686 amino acids long. Of the 15 potential N-linked complete envelope protein diverges by more than 50%
between the two SIVCPZ isolates, only 33% variation isglycosylation sites (sequons) which are highly conserved
within the HIV-1 glycoproteins (2), only 11 were con- found in the V3 domain (the principal neutralizing domain,
PND) which is very low compared with the 80 and 65%served in SIVCPZ-ANT compared with 14 in SIV CPZ-GAB (Fig.
2). In addition, an elevated number of cysteine residues divergences in V1 and V2, respectively. The central part
of the loop contains the QIGPGMTFYN motif (Fig. 2B),was found. Two extra cysteine residues were present at
positions 182 and 190 in the V2 domain of the outer which is identical to the V3 sequence of SIVCPZ-GAB , but
different from all known HIV-1 V3 sequences (2). Thesemembrane protein, while the signal peptide sequence
was devoid of the cysteine residue which is highly con- results are intriguing since the V3 sequence is hypervari-
able in HIV-1, whereas the sequences obtained for theserved in HIV-1 and SIVCPZ-GAB (2). The distribution of
the cysteine residues in the transmembrane part of the two chimpanzee viruses show less divergence compared
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FIG. 1. Phylogenetic relationship of SIVCPZ-ANT to representative primate lentiviruses. Predicted Gag, Pol, and Env protein sequences were aligned
and then concatenated; pairwise distances were calculated by Kimura’s method (30), and the phylogeny was estimated by the neighbor-joining
method (31) with 1000 bootstraps; these methods were implemented using CLUSTAL W (32). The tree is midpoint rooted. Horizontal branch lengths
are to scale: the bar indicates 10% (0.10 amino acid replacements per site). All clusters within the HIV-1/SIVCPZ lineage were found in 100% of
bootstraps. The same branching order within the HIV-1/SIVCPZ lineage was found in trees estimated from Gag, Pol, and Env proteins analyzed
individually and in trees estimated by the maximum parsimony and weighted parsimony methods.
FIG. 2. Envelope protein of SIVCPZ-ANT . (A) Representation of SIVCPZ-ANT (a) and SIVCPZ-GAB (b). Potential N-glycosylation sites (NXS or NXT) are
indicated with s when highly conserved in HIV-1, other sites are designated by l. The positions of cysteine residues are shown below the line,
and arrows indicate cysteine residues unique at that position for each SIVCPZ isolate. The Prosite program of PCgene software was used to localize
the potential N-glycosylation sites. Potential glycosylation sites at positions 45 and 125 (SIVCPZ-ANT) are followed by a proline residue and are
therefore not indicated (33). (B) V3 sequence comparison of both SIVCPZ strains (top) and of HIV-1 strains belonging to different subtypes as indicated.
The alignment was produced using CLUSTAL W (32), with minor manual adjustment. Residues conserved between the two SIVCPZ or within HIV-1
group M or group O are indicated in capital letters; those conserved across all sequences are in bold.
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FIG. 3. Vpu protein of SIVCPZ-ANT . (A) Alignment of Vpu proteins from SIVCPZ-ANT , SIVCPZ-GAB , HIV-1 M, and HIV-1 O isolates using CLUSTAL W.
Residues identical across all four sequences are indicated by *. The HIV-1 conserved Vpu motif is underlined. (B) Hydropathy profiles of the
SIVCPZ-ANT (left) and SIVCPZ-GAB (right) Vpu proteins were calculated according to Kyte and Doolittle (34). Positive scores are hydrophobic and the
amino acid number is indicated on the X-axis.
with their complete envelope proteins. The similarity be- not at the same position (Fig. 2). The WDINDL box which
is located at the C-terminus of the protein has also beentween the two SIVCPZ sequences does not extend beyond
the V3 loop and therefore seems unlikely to be due to described as critical for the functioning of Vpu (21). This
motif is conserved in group M isolates, but not in therecombination between these two lineages. Variation is
also limited in the V3 sequences of isolates obtained SIVCPZ isolates or in group O strains (2). This observation
is in keeping with previous data which indicate that pro-from one infected animal as shown in a study of consecu-
tive isolates obtained from the SIVCPZ-ANT-infected chim- teins with identical or similar functions and structure do
not need sharing of extensive sequence similarity (22).panzee (15). Noting that, unlike HIV-1, the V3 domain in
SIVMAC from macaques is not involved in neutralization In conclusion, as part of an ongoing international effort
to document the genetic variation of SIV and HIV, we(18), these observations raise the question whether the
V3 domain in SIVCPZ is functionally equivalent to the PND have studied a new lentivirus, SIVCPZ-ANT , isolated from a
wild captured chimpanzee. While this virus clearly be-of HIV-1. The low degree of variation found in the V3
region of HIV-1 viruses upon infection of chimpanzees longs to the HIV-1 lineage of primate lentiviruses, it is
by far the most divergent representative of this lineage(19) may indicate that these animals react differently to
lentivirus infections compared to humans. discovered at present. The virus does not cluster with the
two previously characterized SIVCPZ isolates, but ratherThe most divergent protein of SIVCPZ-ANT is the auxiliary
protein Vpu. This protein showed little sequence similar- forms an outgroup to all presently known SIVCPZ and HIV-
1 isolates. The phylogenetic position of SIVCPZ-ANT alsoity with Vpu of SIVCPZ-GAB despite its comparable length
of 83 amino acids (Table 1). Apart from its position in the prompts speculation about the origin(s) of HIV-1 and
SIVCPZ . Clearly, it is no longer more parsimonious to sug-genome, vpu was identifiable by the hydropathy profile
displayed by its deduced protein (Fig. 3). The N-terminal gest that a human virus has been transmitted to chimpan-
zees (10, 11). Furthermore, unless it is argued that SIVCPZ-portion is hydrophobic and corresponds to the putative
membrane anchor domain as has been suggested for GAB was transferred from humans to chimpanzees, it is
clear that the two major clusters of HIV-1, groups M andHIV-1 (20). Vpu, which is also divergent among HIV-1
variants, usually contains a highly conserved region of O, must have arisen by two independent introductions
into the human population. However, it is not known11 amino acids. Only 3 of the 11 residues are conserved
in SIVCPZ-ANT , and the residues assumed to be involved whether the common ancestor of the entire HIV-1/SIVCPZ
lineage has infected chimpanzees. The phylogenetic re-in the degradation process of the cellular CD4 receptor
are absent (20). However, the serine residues probably lationships of the currently known viruses would seem
to indicate this, but the low seroprevalence among chim-important for protein phosphorylation are retained, albeit
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